Falliers C J, Tinkelman D G
Clin Chest Med. 1986 Sep;7(3):383-91.
Individualized management of asthma requires consideration of single or combined pharmacologic alternatives. This article reviews experimental and clinical data on the efficacy, safety, mode of action, and therapeutic indications for cromolyn and related inhalational compounds; ketotifen; alpha-adrenergic blockers; calcium-channel blockers; nonsteroidal anti-inflammatory drugs; and such diverse agents as immunosuppressive drugs, ether, alcohol, ascorbic acid, and other nutritional substances.
哮喘的个体化管理需要考虑单一或联合的药物选择。本文综述了色甘酸钠及相关吸入性化合物、酮替芬、α-肾上腺素能阻滞剂、钙通道阻滞剂、非甾体抗炎药以及免疫抑制药物、乙醚、酒精、抗坏血酸和其他营养物质等多种药物的实验和临床数据，包括其疗效、安全性、作用方式和治疗适应证。
